AzTrials
AzTrials

Osteoarthritis, KneeNCT04717167

The Effect of Dry Needling in Patients With Knee Osteoarthritis

A study testing Dry Needling in people with Osteoarthritis, Knee, run by Universiteit Antwerpen.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Research suggests that myofascial trigger points (MTrP) play an important role in explaining pain in patients with musculoskeletal knee disorders. Trigger points are usually defined as hypersensitive tender spots within taut bands of skeletal muscles that are painful on muscle stimulation and that usually elicit… Read more about this study

Who is it for?
Ages 50 years and older
Conditions the study is for
Osteoarthritis, Knee
What is being tested?
Dry Needling
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
61 participants
Where
No sites listed yet
Study dates
1 Dec 2016to 1 Apr 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • A minimum age of fifty years old;
  • Diagnosed with KOA based on the American College of Rheumatology (ACR) clinical classification criteria(48), including:
  • A Kellgren-Lawrence grade of minimum two on radiography;
  • At least three months of chronical knee pain.

Who cannot join

  • Patients suffering from autoimmune and/or neurological disorders
  • Patients who had a major trauma/fracture of the lower limb in the past six months -
  • Patients who experienced other musculoskeletal problems than OA

About this study

Official title: The Effect of One Dry Needling Session on Pain and Central Pain Processing in Patients With Knee Osteoarthritis: a Randomized Controlled Trial

Research suggests that myofascial trigger points (MTrP) play an important role in explaining pain in patients with musculoskeletal knee disorders. Trigger points are usually defined as hypersensitive tender spots within taut bands of skeletal muscles that are painful on muscle stimulation and that usually elicit referred pain. Treatment of these trigger points could possibly alleviate symptoms in patients with knee pain. However, literature on the effect of trigger point therapy, dry needling in particular, in patients with musculoskeletal knee disorders is scarce. The purpose of this study is to examine the effect of trigger point therapy (dry needling (DN)) on pain, presence of altered central pain processing, muscle features and gait pattern in patients with knee osteoarthritis (KOA). 60 patients with symptomatic KOA will participate in this study. They will randomly be allocated in either an experimental group (EG) (dry needling technique) or a placebo group (PG) (sham needling technique). Pain (Visual analogue scale (VAS) \& KOA outcome score (KOOS), muscle features during gait and gait pattern (3D gait analysis and surface electroMyoGraphy (EMG)) and presence of altered central pain processing (Central Sensitization Inventory (CSI), Quantitative Sensory testing (QST)) will be measured at baseline and 15 minutes after the intervention. Additionally, pain will be measured 3 days after the intervention. The investigators hypothesize that the effect on the outcome measures will be significantly larger in the EG compared to the PG.

Being tested
Dry Needling, Sham Needling
Keywords
dry needling, central pain processing, pain, EMG measurements, muscle coactivation, gait pattern
Medical subject headings
Osteoarthritis, Knee, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04717167
Study groupRoleWhat they receive
DN groupExperimentalAll identified MTrPs were inserted with a sterile filiform needle (0,30mm x 40mm or 0,30mm x 75mm, depending on the muscle) that moved up- and downwards until a local twitch response was elicited. When the repeated local twitch response fade away or the subject reported too much pain, the needle was removed. After the treatment, a 15 minutes break(51) was set up and the subjects were not permitted to use a hot pack or to stretch the muscle.
Receives: Other: Dry Needling
Sham needling (SN) groupSham comparatorThe SN technique was similar to DN, except for penetrating the muscle. In this technique, the needle only penetrated the skin and was therefore impossible to provoke a local twitch response.
Receives: Other: Sham Needling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain sensation

    Measured with a Visual Analogue Scale, scored from 0 to 100, where higher scores indicate higher pain sensation.

    Measured: Change from baseline pain sensation at 15minutes postintervention

  2. Pain sensation

    Measured with the Knee Osteoarthritis Outcome Score- subscale pain, scored on a scale from 0 to 36, transferred from 0 to 100. Higher scores indicate a higher pain sensation.

    Measured: Change from baseline pain sensation at 15minutes postintervention

  3. Pain sensation

    Measured with a Visual Analogue Scale, scored from 0 to 100, where higher scores indicate higher pain sensation.

    Measured: Change from baseline pain sensation at 3days postintervention

  4. Pain sensation

    Measured with the Knee Osteoarthritis Outcome Score- subscale pain, scored on a scale from 0 to 36, transferred from 0 to 100. Higher scores indicate a higher pain sensation.

    Measured: Change from baseline pain sensation at 3days postintervention

  5. Pain sensation

    Measured with a Visual Analogue Scale, scored from 0 to 100, where higher scores indicate higher pain sensation.

    Measured: Change from 15minutes postintervention pain sensation at 3days postintervention

  6. Pain sensation

    Measured with the Knee Osteoarthritis Outcome Score- subscale pain, scored on a scale from 0 to 36, transferred from 0 to 100. Higher scores indicate a higher pain sensation.

    Measured: Change from 15minutes postintervention pain sensation at 3days postintervention

  7. Pain pressure thresholds

    Measured with an digital algometer (kilogram force/ square cm)

    Measured: Change from baseline central pain processing at 15minutes postintervention

  8. Temporal summation

    Measured with an digital algometer (kilogram force/ square cm)

    Measured: Change from baseline central pain processing at 15minutes postintervention

  9. Conditioned pain modulation

    Measured with an digital algometer (test stimulus) and an inflatable cuff (conditioning stimulus). (kilogram force/ square cm)

    Measured: Change from baseline central pain processing at 15minutes postintervention

Secondary outcomes (12)
  1. Muscle coactivation of musculus Vastus medialis and musculus Semitendinosus

    Measured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.

    Measured: Change from baseline muscle coactivation at 15minutes postintervention

  2. Muscle coactivation of musculus Vastus medialis and musculus Biceps femoris

    Measured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.

    Measured: Change from baseline muscle coactivation at 15minutes postintervention

  3. Muscle coactivation of musculus Vastus lateralis and musculus Semitendinosus

    Measured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.

    Measured: Change from baseline muscle coactivation at 15minutes postintervention

  4. Muscle coactivation of musculus Vastus lateralis and musculus Biceps femoris

    Measured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.

    Measured: Change from baseline muscle coactivation at 15minutes postintervention

  5. Muscle coactivation of musculus Tibialis anterior and musculus Gastrocnemius medialis

    Measured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.

    Measured: Change from baseline muscle coactivation at 15minutes postintervention

  6. Muscle coactivation of musculus Tibialis anterior and musculus Gastrocnemius lateralis

    Measured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.

    Measured: Change from baseline muscle coactivation at 15minutes postintervention

  7. Stride time (seconds)

    measured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.

    Measured: Change from baseline muscle coactivation at 15minutes postintervention

  8. Stride length (meters)

    measured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.

    Measured: Change from baseline muscle coactivation at 15minutes postintervention

  9. Step time (meters/second)

    measured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.

    Measured: Change from baseline muscle coactivation at 15minutes postintervention

  10. Stance phase (%)

    measured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.

    Measured: Change from baseline muscle coactivation at 15minutes postintervention

  11. Step length (meters)

    measured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.

    Measured: Change from baseline muscle coactivation at 15minutes postintervention

  12. Step width (meters)

    measured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.

    Measured: Change from baseline muscle coactivation at 15minutes postintervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jan 2021
  2. Study start1 Dec 2016
  3. Primary completion1 Apr 2019
  4. Study completion1 Apr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Factorial
Model description
One group will receive dry needling session and one group will receive placebo treatment. A simple randomization on a website (www.randomizer.org) performed by a researcher (IB), independent from the executive researchers.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
61 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04717167
Sponsor's protocol ID
B3000201630444
Status last verified
Jan 2021
First submitted
13 Jan 2021
Last updated
20 Jan 2021
Results posted
No
Individual data sharing
No

Publications

  • Vervullens S, Meert L, Baert I, Delrue N, Heusdens CHW, Hallemans A, Van Criekinge T, Smeets RJEM, De Meulemeester K. The effect of one dry needling session on pain, central pain processing, muscle co-contraction and gait characteristics in patients with knee osteoarthritis: a randomized controlled trial. Scand J Pain. 2021 Sep 30;22(2):396-409. doi: 10.1515/sjpain-2021-0091. Print 2022 Apr 26.

    PubMed 34821140

Questions about this trial

What is this clinical trial studying?

A study testing Dry Needling in people with Osteoarthritis, Knee, run by Universiteit Antwerpen.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain sensation (time frame: Change from baseline pain sensation at 15minutes postintervention). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04717167, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2021; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in